Tekla Life Sciences Investors ( HQL) - Stock Earnings
HQL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 50.3 million USD | 2.1 million USD |
| 2024Q1 | 50.3 million USD | 2.1 million USD |
| 2024Q3 | 35.0 million USD | 1.9 million USD |
HQL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -104.6 million USD | -103.3 million USD |
| 2023 | 22.4 million USD | 23.5 million USD |
| 2024 | 85.3 million USD | 86.7 million USD |
HQL
Price: $16.51
Dividend Yield: 11.81%
Forward Dividend Yield: 13.35%
Payout Ratio: 146.27%
Dividend Per Share: 2.24 USD
Earnings Per Share: 2.79 USD
P/E Ratio: 5.77
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Country: United States
Volume: 93486
Market Capitalization: 525.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 31
DGR3: 8.01%
DGR5: 7.16%
DGR10: 0.66%
DGR20: 22.46%